Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Lingor

Showing results (101-110 of 173) with videos related to

Pageof 18
Sort By:
Neurobiology of Disease|March 10, 2010
TGF-beta 1 enhances neurite outgrowth via regulation of proteasome function and EFABPJohanna Knöferle, Sanja Ramljak, Jan C Koch, et al.
Cell Death & Disease|February 27, 2021
AAV-mediated inhibition of ULK1 promotes axonal regeneration in the central nervous system in vitro and in vivoVinicius Toledo Ribas, Björn Friedhelm Vahsen, Lars Tatenhorst, et al.
NPJ Parkinson'S Disease|February 18, 2026
Detection of alpha-synuclein seeding activity in tear fluid in patients with Parkinson's diseaseSezgi Canaslan, Matthias Schmitz, Fabian Maass, et al.
Journal of Neurochemistry|November 13, 2007
Membrane-permeable Bcl-xL prevents MPTP-induced dopaminergic neuronal loss in the substantia nigraGunnar P H Dietz, Kerstin V Stockhausen, Birgit Dietz, et al.
Trials|September 15, 2022
Identifying obstacles hindering the conduct of academic-sponsored trials for drug repurposing on rare-diseases: an analysis of six use casesMarta Del Álamo, Christoph Bührer, Dirk Fisher, et al.
Acta Neuropathologica Communications|September 2, 2025
Identification and validation of a tear fluid-derived protein biomarker signature in patients with amyotrophic lateral sclerosisLena-Sophie Scholl, Antonia F Demleitner, Jenny Riedel, et al.
Frontiers in Aging Neuroscience|October 14, 2014
Alpha-synuclein mutations impair axonal regeneration in models of Parkinson's diseaseLars Tönges, Eva M Szegö, Patrizia Hause, et al.
Journal of Neurology|August 29, 2024
Pharmacotherapy of motor symptoms in early and mid-stage Parkinson's disease: guideline "Parkinson's disease" of the German Society of NeurologyMatthias Höllerhage, Jos Becktepe, Joseph Classen, et al.
Advances in Therapy|June 21, 2017
An Observational Study of the Effect of Levodopa-Carbidopa Intestinal Gel on Activities of Daily Living and Quality of Life in Advanced Parkinson's Disease PatientsRejko Krüger, Paul Lingor, Triantafyllos Doskas, et al.
Acta Neuropathologica Communications|April 23, 2016
Fasudil attenuates aggregation of α-synuclein in models of Parkinson's diseaseLars Tatenhorst, Katrin Eckermann, Vivian Dambeck, et al.
Pageof 18

Showing results (101-110 of 173) with videos related to

Sort By:
Pageof 18
Neurobiology of Disease|March 10, 2010
TGF-beta 1 enhances neurite outgrowth via regulation of proteasome function and EFABPJohanna Knöferle, Sanja Ramljak, Jan C Koch, et al.
Cell Death & Disease|February 27, 2021
AAV-mediated inhibition of ULK1 promotes axonal regeneration in the central nervous system in vitro and in vivoVinicius Toledo Ribas, Björn Friedhelm Vahsen, Lars Tatenhorst, et al.
NPJ Parkinson'S Disease|February 18, 2026
Detection of alpha-synuclein seeding activity in tear fluid in patients with Parkinson's diseaseSezgi Canaslan, Matthias Schmitz, Fabian Maass, et al.
Journal of Neurochemistry|November 13, 2007
Membrane-permeable Bcl-xL prevents MPTP-induced dopaminergic neuronal loss in the substantia nigraGunnar P H Dietz, Kerstin V Stockhausen, Birgit Dietz, et al.
Trials|September 15, 2022
Identifying obstacles hindering the conduct of academic-sponsored trials for drug repurposing on rare-diseases: an analysis of six use casesMarta Del Álamo, Christoph Bührer, Dirk Fisher, et al.
Acta Neuropathologica Communications|September 2, 2025
Identification and validation of a tear fluid-derived protein biomarker signature in patients with amyotrophic lateral sclerosisLena-Sophie Scholl, Antonia F Demleitner, Jenny Riedel, et al.
Frontiers in Aging Neuroscience|October 14, 2014
Alpha-synuclein mutations impair axonal regeneration in models of Parkinson's diseaseLars Tönges, Eva M Szegö, Patrizia Hause, et al.
Journal of Neurology|August 29, 2024
Pharmacotherapy of motor symptoms in early and mid-stage Parkinson's disease: guideline "Parkinson's disease" of the German Society of NeurologyMatthias Höllerhage, Jos Becktepe, Joseph Classen, et al.
Advances in Therapy|June 21, 2017
An Observational Study of the Effect of Levodopa-Carbidopa Intestinal Gel on Activities of Daily Living and Quality of Life in Advanced Parkinson's Disease PatientsRejko Krüger, Paul Lingor, Triantafyllos Doskas, et al.
Acta Neuropathologica Communications|April 23, 2016
Fasudil attenuates aggregation of α-synuclein in models of Parkinson's diseaseLars Tatenhorst, Katrin Eckermann, Vivian Dambeck, et al.
Pageof 18